St. Jude Medical Inc. announced the U.S. Food and Drug Administration (FDA) approval and launch of its Ilumien Optis PCI optimization system, a new technology designed to provide physicians with a comprehensive disease assessment tool for treating patients with coronary artery disease (CAD). The system will be on display for the first time in the United States during the 2013 Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium in San Francisco.

October 22, 2013 — AtheroMed, a developer of catheter technologies for treating peripheral artery disease (PAD), announced results from its Endovascular Atherectomy Safety and Effectiveness (EASE) study during a late-breaking clinical trials session at the Vascular Interventional Advances (VIVA) 2013 conference in Las Vegas. Stephen Williams, M.D., director of the Vascular Medicine Center, Johns Hopkins University, presented the results of the study, which demonstrate the safety and effectiveness of the Phoenix atherectomy system in treating PAD.

A 56-year-old man who had a heart attack survived and is recovering at home after receiving two hours and forty-five minutes of cardiopulmonary resuscitation (CPR). The length of CPR time is believed to be among the longest on record and was made possible because of a mechanical chest compression machine called the Lucas device.

AngioScore Inc., a developer of angioplasty catheters for use in the treatment of cardiovascular disease, announced that preliminary data from the first-in-human (FIH) study (“Patent-C”) of the drug-coated AngioSculpt Scoring Balloon Catheter will be presented at the Transcatheter Cardiovascular Therapeutics (TCT) Conference in San Francisco the week of Oct. 28.

heart valve repair medtronic corevalve evolut recapturable

Medtronic Inc. announced the first implants in the CoreValve Evolut R clinical study, which will evaluate the safety and effectiveness of the CoreValve Evolut R recapturable system. This recapture-enabled valve and delivery system is designed to advance deliverability and valve performance while providing the option to recapture and reposition the CoreValve Evolut R valve during deployment, if needed, while performing transcatheter aortic valve implantation (TAVI).

Nuclear Imaging Services LLC (NIS) has completed the first U.S.-based ECAT Scintron installation into an outpatient cardiology facility. Gulf Coast Cardiology Group in Port Arthur, Texas, is the first to upgrade its Siemens ECAT system to Medical Imaging Electronics' (MiE) ECAT Scintron.

Epsilon Imaging Inc., a visualization and analysis software provider, announced the launch of its newest application specifically designed for right ventricle (RV) assessment. EchoInsight computer-aided visualization and analysis offers quick and intuitive strain imaging along with automated cardiac function measurements for enhanced confidence and workflow in echo interpretation.

By Dave Fornell, DAIC Editor

The Cardiovascular Research Foundation’s (CRF) Transcatheter Cardiovascular Therapeutics (TCT) 2013 scientific symposium Oct. 27 – Nov. 1 in San Francisco is celebrating its 25th anniversary. The event has grown from a couple hundred attendees its first year to more than 12,000 attendees expected this year. TCT has grown from a small niche meeting focused on angioplasty to an international gathering that encompasses the entire spectrum of emerging catheter-based technologies and techniques.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now